Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)
Muro, Kei, Dr, Boku, Narikazu, MD, Shimada, Yasuhiro, MD, Tsuji, Akihito, MD, Sameshima, Shinichi, MD, Baba, Hideo, Prof, Satoh, Taroh, MD, Denda, Tadamichi, MD, Ina, Kenji, MD, Nishina, Tomohiro, MD, Yamaguchi, Kensei, MD, Takiuchi, Hiroya, Prof, Esaki, Taito, MD, Tokunaga, Shinya, MD, Kuwano, Hiroyuki, Prof, Komatsu, Yoshito, MD, Watanabe, Masahiko, Prof, Hyodo, Ichinosuke, Prof, Morita, Satoshi, Prof, Sugihara, Kenichi, Prof
Published in The lancet oncology (01.09.2010)
Published in The lancet oncology (01.09.2010)
Get full text
Journal Article
S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial
Hironaka, Shuichi, Dr, Sugimoto, Naotoshi, MD, Yamaguchi, Kensei, MD, Moriwaki, Toshikazu, MD, Komatsu, Yoshito, MD, Nishina, Tomohiro, MD, Tsuji, Akihito, MD, Nakajima, Takako Eguchi, MD, Gotoh, Masahiro, MD, Machida, Nozomu, MD, Bando, Hideaki, MD, Esaki, Taito, MD, Emi, Yasunori, MD, Sekikawa, Takashi, MD, Matsumoto, Shigemi, MD, Takeuchi, Masahiro, Prof, Boku, Narikazu, Prof, Baba, Hideo, Prof, Hyodo, Ichinosuke, Prof
Published in The lancet oncology (01.01.2016)
Published in The lancet oncology (01.01.2016)
Get full text
Journal Article